Trial Profile
The effection and mechanism of Fudosteine used in hypertension patients company with obstructive sleep apnea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Fudosteine (Primary)
- Indications Sleep apnoea syndrome
- Focus Biomarker; Pharmacodynamics
- 16 Apr 2016 Status changed from not yet recruiting to completed according to the Chinese Clinical Trial Register record.
- 18 Oct 2013 New trial record